Dihydroergotoxine Methanesulfonate en es it fr

Dihydroergotoxine Methanesulfonate Brand names, Dihydroergotoxine Methanesulfonate Analogs

Dihydroergotoxine Methanesulfonate Brand Names Mixture

  • No information avaliable

Dihydroergotoxine Methanesulfonate Chemical_Formula

C33H45N5O5

Dihydroergotoxine Methanesulfonate RX_link

No information avaliable

Dihydroergotoxine Methanesulfonate fda sheet

Dihydroergotoxine Methanesulfonate msds (material safety sheet)

Dihydroergotoxine Methanesulfonate Synthesis Reference

No information avaliable

Dihydroergotoxine Methanesulfonate Molecular Weight

591.741 g/mol

Dihydroergotoxine Methanesulfonate Melting Point

No information avaliable

Dihydroergotoxine Methanesulfonate H2O Solubility

No information avaliable

Dihydroergotoxine Methanesulfonate State

Solid

Dihydroergotoxine Methanesulfonate LogP

2.615

Dihydroergotoxine Methanesulfonate Dosage Forms

Capsule; Liquid; Powder; Powder for solution; Solution; Syrup; Tablet

Dihydroergotoxine Methanesulfonate Indication

For use as an adjunct therapy for patients with dementia

Dihydroergotoxine Methanesulfonate Pharmacology

Ergoloid Mesylate may increase cerebral metabolism and blood flow. The role of this medication in the therapy of dementia is controversial. A recent controlled study in patients with Alzheimer's disease found that there was no advantage to the use of ergoloid mesylates compared to placebo, suggesting that ergoloid mesylates may lower scores on some cognitive and behavioral rating scales. Further study is needed to determine the risk-benefit profile of ergoloid mesylates in the treatment of dementia.

Dihydroergotoxine Methanesulfonate Absorption

Rapidly but incompletely (approximately 25%) absorbed from the gastrointestinal tract. Approximately 50% of the absorbed dose is eliminated by first-pass metabolism.

Dihydroergotoxine Methanesulfonate side effects and Toxicity

Symptoms of overdose include dyspnea, hypotension or hypertension, rapid weak pulse, delirium, nausea, vomiting, and bradycardia.

Dihydroergotoxine Methanesulfonate Patient Information

No information avaliable

Dihydroergotoxine Methanesulfonate Organisms Affected

Humans and other mammals